MolecularBreastImagingCAMOophorectomyDoseDenseTherapyKi-67Rate5-FluorouracilPalbociclibMetastasisMultifocalTumorsBilateralProphylacticMastectomyBOCAHerceptinDimplingBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EndometrialCancerMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPathologicResponseLapatinibRadiotherapyEstradiolAxillarySamplingApoptosisDefinitiveSurgeryCDK4/6InhibitorsAyurvedaER-NeoplasmGailModelGuaranteedRenewableInsuranceNodeNegativeCytotoxicGeneticCounselingIntraductalPapillomaDoxorubicinLymphNodeStatusMorpheaPrecisionMedicineAnastrozoleDisease-FreeSurvivalRateAntibodyTherapyAntiemeticAngiogenesisCalcificationsMultimodalityTherapyRaloxifeneBRCAGeneCyclophosphamideMastalgiaFibroadenomaCapecitabineChemopreventionEGFR(epidermalgrowth factorreceptor)ExcisionalBiopsy1 in 8womenPaclitaxelChemotherapyGeneticPredispositionBenignPhyllodesTumormTORInhibitorsLumpGeneMutationEvidencesuggests thatphysical activitymay reduce therisk of breastcancersAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenGenomicTestingBrachytherapyFamilyHistoryBI-RADSTripleNegativeBreastCancerAdjuvantTherapyAdvocacyFlowCytometryFISHAdenocarcinomaCytostaticMastitisTyrosine-KinaseInhibitorRelapseAromataseInhibitorsBreastCancerAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDocetaxelRADCo-survivorMastodyniaBiopsyCheckpointInhibitorPalpationSelf-examinationDown-StagingNeoadjuvantTherapyBreastTomosynthesisER+AlopeciaPARPInhibitorsOvarianSuppressionEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAbsoluteRiskStagingLymphoscintigraphyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.In-situCarcinomaSERMInvasiveBreastCancerTumorGradeMetastaticBreastCancerBevacizumabCMFChemotherapyEstrogenLumpectomyPhyllodesTumorNodePositiveKappaEpsilonHER-2MegestrolAcetateDiabeticMastopathyCachexiaMRIImmunotherapyHormoneReplacementTherapyLiquidBiopsyProgestinTamoxifenWomen ages40+ shouldhave a clinicalbreast examat least yearlyHormoneReceptorStatusSclerosingAdenosisECOGScoreGermlineMutationPI3KinaseInhibitorsCystPagetDiseaseFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.TriplePositiveBreastCancerOligometastasesLCISMethotrexateACChemotherapyMastectomylatissimusflapMolecularBreastImagingCAMOophorectomyDoseDenseTherapyKi-67Rate5-FluorouracilPalbociclibMetastasisMultifocalTumorsBilateralProphylacticMastectomyBOCAHerceptinDimplingBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EndometrialCancerMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPathologicResponseLapatinibRadiotherapyEstradiolAxillarySamplingApoptosisDefinitiveSurgeryCDK4/6InhibitorsAyurvedaER-NeoplasmGailModelGuaranteedRenewableInsuranceNodeNegativeCytotoxicGeneticCounselingIntraductalPapillomaDoxorubicinLymphNodeStatusMorpheaPrecisionMedicineAnastrozoleDisease-FreeSurvivalRateAntibodyTherapyAntiemeticAngiogenesisCalcificationsMultimodalityTherapyRaloxifeneBRCAGeneCyclophosphamideMastalgiaFibroadenomaCapecitabineChemopreventionEGFR(epidermalgrowth factorreceptor)ExcisionalBiopsy1 in 8womenPaclitaxelChemotherapyGeneticPredispositionBenignPhyllodesTumormTORInhibitorsLumpGeneMutationEvidencesuggests thatphysical activitymay reduce therisk of breastcancersAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenGenomicTestingBrachytherapyFamilyHistoryBI-RADSTripleNegativeBreastCancerAdjuvantTherapyAdvocacyFlowCytometryFISHAdenocarcinomaCytostaticMastitisTyrosine-KinaseInhibitorRelapseAromataseInhibitorsBreastCancerAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerDocetaxelRADCo-survivorMastodyniaBiopsyCheckpointInhibitorPalpationSelf-examinationDown-StagingNeoadjuvantTherapyBreastTomosynthesisER+AlopeciaPARPInhibitorsOvarianSuppressionEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAbsoluteRiskStagingLymphoscintigraphyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.In-situCarcinomaSERMInvasiveBreastCancerTumorGradeMetastaticBreastCancerBevacizumabCMFChemotherapyEstrogenLumpectomyPhyllodesTumorNodePositiveKappaEpsilonHER-2MegestrolAcetateDiabeticMastopathyCachexiaMRIImmunotherapyHormoneReplacementTherapyLiquidBiopsyProgestinTamoxifenWomen ages40+ shouldhave a clinicalbreast examat least yearlyHormoneReceptorStatusSclerosingAdenosisECOGScoreGermlineMutationPI3KinaseInhibitorsCystPagetDiseaseFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.TriplePositiveBreastCancerOligometastasesLCISMethotrexateACChemotherapyMastectomylatissimusflap

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Molecular Breast Imaging
  2. CAM
  3. Oophorectomy
  4. Dose Dense Therapy
  5. Ki-67 Rate
  6. 5-Fluorouracil
  7. Palbociclib
  8. Metastasis
  9. Multifocal Tumors
  10. Bilateral Prophylactic Mastectomy
  11. BOCA
  12. Herceptin
  13. Dimpling
  14. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  15. Endometrial Cancer
  16. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  17. Pathologic Response
  18. Lapatinib
  19. Radiotherapy
  20. Estradiol
  21. Axillary Sampling
  22. Apoptosis
  23. Definitive Surgery
  24. CDK4/6 Inhibitors
  25. Ayurveda
  26. ER-
  27. Neoplasm
  28. Gail Model
  29. Guaranteed Renewable Insurance
  30. Node Negative
  31. Cytotoxic
  32. Genetic Counseling
  33. Intraductal Papilloma
  34. Doxorubicin
  35. Lymph Node Status
  36. Morphea
  37. Precision Medicine
  38. Anastrozole
  39. Disease-Free Survival Rate
  40. Antibody Therapy
  41. Antiemetic
  42. Angiogenesis
  43. Calcifications
  44. Multimodality Therapy
  45. Raloxifene
  46. BRCA Gene
  47. Cyclophosphamide
  48. Mastalgia
  49. Fibroadenoma
  50. Capecitabine
  51. Chemoprevention
  52. EGFR (epidermal growth factor receptor)
  53. Excisional Biopsy
  54. 1 in 8 women
  55. Paclitaxel
  56. Chemotherapy
  57. Genetic Predisposition
  58. Benign Phyllodes Tumor
  59. mTOR Inhibitors
  60. Lump
  61. Gene Mutation
  62. Evidence suggests that physical activity may reduce the risk of breast cancers
  63. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  64. Genomic Testing
  65. Brachytherapy
  66. Family History
  67. BI-RADS
  68. Triple Negative Breast Cancer
  69. Adjuvant Therapy
  70. Advocacy
  71. Flow Cytometry
  72. FISH
  73. Adenocarcinoma
  74. Cytostatic
  75. Mastitis
  76. Tyrosine-Kinase Inhibitor
  77. Relapse
  78. Aromatase Inhibitors
  79. Breast Cancer
  80. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  81. Docetaxel
  82. RAD
  83. Co-survivor
  84. Mastodynia
  85. Biopsy
  86. Checkpoint Inhibitor
  87. Palpation
  88. Self-examination
  89. Down-Staging
  90. Neoadjuvant Therapy
  91. Breast Tomosynthesis
  92. ER+
  93. Alopecia
  94. PARP Inhibitors
  95. Ovarian Suppression
  96. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  97. Absolute Risk
  98. Staging
  99. Lymphoscintigraphy
  100. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  101. In-situ Carcinoma
  102. SERM
  103. Invasive Breast Cancer
  104. Tumor Grade
  105. Metastatic Breast Cancer
  106. Bevacizumab
  107. CMF Chemotherapy
  108. Estrogen
  109. Lumpectomy
  110. Phyllodes Tumor
  111. Node Positive
  112. Kappa Epsilon
  113. HER-2
  114. Megestrol Acetate
  115. Diabetic Mastopathy
  116. Cachexia
  117. MRI
  118. Immunotherapy
  119. Hormone Replacement Therapy
  120. Liquid Biopsy
  121. Progestin
  122. Tamoxifen
  123. Women ages 40+ should have a clinical breast exam at least yearly
  124. Hormone Receptor Status
  125. Sclerosing Adenosis
  126. ECOG Score
  127. Germline Mutation
  128. PI3 Kinase Inhibitors
  129. Cyst
  130. Paget Disease
  131. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  132. Triple Positive Breast Cancer
  133. Oligometastases
  134. LCIS
  135. Methotrexate
  136. AC Chemotherapy
  137. Mastectomy
  138. latissimus flap